Incremental prognostic value of echocardiography of left ventricular remodeling and diastolic function in STICH trial.

Publication Year: 2020

DOI:
10.1186/s12947-020-00195-1

PMCID:
PMC7257201

PMID:
32466790

Journal Information

Full Title: Cardiovasc Ultrasound

Abbreviation: Cardiovasc Ultrasound

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Diagnostic Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests Paul Grayburn: Consultant for Tendyne and Abbott Vascular; Grant support from Abbot Vascular and Medtronic; Echo core lab contract for ValTech Cardio, Guided Delivery Systems, and Tendyne David Prior; Consultant for Actelion, Astra-Zeneca and Servier. There are no other relationships with industry to disclose."

Evidence found in paper:

"Funding This work was supported by the National Institutes of Health, Heart, Lung, and Blood Institute grants (U01HL69015, U01HL69013, and U01HL69010) (ClinicalTrials.gov #NCT00023595; www.stichtrial.org NCT00023595). The views expressed in this manuscript do not necessarily reflect those of the NIH or NHLBI."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025